$60,000 of CORTEVA AGRISCIENCE lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"EPA regulatory issues pertaining to pesticides."
You can find more data on corporate lobbying on Quiver Quantitative.
CTVA Congressional Stock Trading
Members of Congress have traded $CTVA stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CTVA stock by members of Congress over the last 6 months:
- SENATOR TOMMY TUBERVILLE sold up to $15,000 on 10/29.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CTVA Insider Trading Activity
CTVA insiders have traded $CTVA stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $CTVA stock by insiders over the last 6 months:
- CHARLES V. MAGRO (Chief Executive Officer) sold 46,905 shares for an estimated $2,993,477
- CORNEL B FUERER (SVP, Gen Counsel and Secretary) sold 37,672 shares for an estimated $2,388,367
- BRIAN TITUS (See Remarks) sold 26,560 shares for an estimated $1,692,934
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CTVA Hedge Fund Activity
We have seen 526 institutional investors add shares of CTVA stock to their portfolio, and 505 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL WORLD INVESTORS added 12,381,436 shares (+2874.6%) to their portfolio in Q4 2024, for an estimated $705,246,594
- INDEPENDENT FRANCHISE PARTNERS LLP added 5,604,838 shares (+51.5%) to their portfolio in Q4 2024, for an estimated $319,251,572
- NUVEEN ASSET MANAGEMENT, LLC removed 3,466,156 shares (-24.6%) from their portfolio in Q4 2024, for an estimated $197,432,245
- GLENVIEW CAPITAL MANAGEMENT, LLC removed 3,187,473 shares (-60.8%) from their portfolio in Q4 2024, for an estimated $181,558,462
- BOSTON PARTNERS removed 2,447,663 shares (-72.3%) from their portfolio in Q4 2024, for an estimated $139,418,884
- DUPONT CAPITAL MANAGEMENT CORP removed 1,949,165 shares (-45.8%) from their portfolio in Q4 2024, for an estimated $111,024,438
- FRANKLIN RESOURCES INC removed 1,517,170 shares (-8.6%) from their portfolio in Q4 2024, for an estimated $86,418,003
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CTVA Analyst Ratings
Wall Street analysts have issued reports on $CTVA in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 12/19/2024
- KeyBanc issued a "Overweight" rating on 11/21/2024
To track analyst ratings and price targets for CTVA, check out Quiver Quantitative's $CTVA forecast page.
CTVA Price Targets
Multiple analysts have issued price targets for $CTVA recently. We have seen 2 analysts offer price targets for $CTVA in the last 6 months, with a median target of $68.5.
Here are some recent targets:
- Aleksey Yefremov from KeyBanc set a target price of $69.0 on 11/21/2024
- Patrick Cunningham from Citigroup set a target price of $68.0 on 10/23/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
